Valion Bio, Inc. (VBIO) Net income 2021–2025
Valion Bio, Inc. (VBIO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$8.9MFY2025 · since FY2021: -$8.5M → -$8.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.9M | -57.0% |
| FY2024 | -$5.7M | +31.4% |
| FY2023 | -$8.2M | +18.3% |
| FY2022 | -$10.1M | -18.9% |
| FY2021 | -$8.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VBIO financial trends
VBIO RevenueVBIO Net marginVBIO Gross profitVBIO Gross marginVBIO Operating incomeVBIO Operating marginVBIO Operating cash flowVBIO Free cash flowVBIO Capital expendituresVBIO Return on equityVBIO Stock buybacksVBIO Dividends paidVBIO Total assetsVBIO Total liabilitiesVBIO Shareholders’ equityVBIO overview →